![Co-inhibition of BCL-XL and MCL-1 with BCL-2 selective inhibitors A1331852 and S63845 enhances cytotoxicity of cervical cancer cell lines | bioRxiv Co-inhibition of BCL-XL and MCL-1 with BCL-2 selective inhibitors A1331852 and S63845 enhances cytotoxicity of cervical cancer cell lines | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2019/10/30/824649/F4.large.jpg)
Co-inhibition of BCL-XL and MCL-1 with BCL-2 selective inhibitors A1331852 and S63845 enhances cytotoxicity of cervical cancer cell lines | bioRxiv
![IJMS | Free Full-Text | BCL-xL, a Mitochondrial Protein Involved in Successful Aging: From C. elegans to Human Centenarians | HTML IJMS | Free Full-Text | BCL-xL, a Mitochondrial Protein Involved in Successful Aging: From C. elegans to Human Centenarians | HTML](https://www.mdpi.com/ijms/ijms-21-00418/article_deploy/html/images/ijms-21-00418-g001.png)
IJMS | Free Full-Text | BCL-xL, a Mitochondrial Protein Involved in Successful Aging: From C. elegans to Human Centenarians | HTML
![XPO1 inhibitor KPT-330 synergizes with Bcl-xL inhibitor to induce cancer cell apoptosis by perturbing rRNA processing and Mcl-1 protein synthesis.,Cell Death & Disease - X-MOL XPO1 inhibitor KPT-330 synergizes with Bcl-xL inhibitor to induce cancer cell apoptosis by perturbing rRNA processing and Mcl-1 protein synthesis.,Cell Death & Disease - X-MOL](https://xpic.x-mol.com/20190522%2F10.1038_s41419-019-1627-9.jpg)
XPO1 inhibitor KPT-330 synergizes with Bcl-xL inhibitor to induce cancer cell apoptosis by perturbing rRNA processing and Mcl-1 protein synthesis.,Cell Death & Disease - X-MOL
![Radiosensitization by a novel Bcl-2 and Bcl-X L inhibitor S44563 in small-cell lung cancer | Cell Death & Disease Radiosensitization by a novel Bcl-2 and Bcl-X L inhibitor S44563 in small-cell lung cancer | Cell Death & Disease](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fcddis.2014.365/MediaObjects/41419_2014_Article_BFcddis2014365_Fig1_HTML.jpg)
Radiosensitization by a novel Bcl-2 and Bcl-X L inhibitor S44563 in small-cell lung cancer | Cell Death & Disease
![Why do BCL-2 inhibitors work and where should we use them in the clinic? | Cell Death & Differentiation Why do BCL-2 inhibitors work and where should we use them in the clinic? | Cell Death & Differentiation](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fcdd.2017.183/MediaObjects/41418_2018_Article_BFcdd2017183_Fig1_HTML.jpg)
Why do BCL-2 inhibitors work and where should we use them in the clinic? | Cell Death & Differentiation
BH3 mimetics (2). (A) BCL-XL and BCL-2 inhibitor derived from ABT-737;... | Download Scientific Diagram
BM-1197: A Novel and Specific Bcl-2/Bcl-xL Inhibitor Inducing Complete and Long-Lasting Tumor Regression In Vivo
![Selective targeting of antiapoptotic BCL‐2 proteins in cancer - Timucin - 2019 - Medicinal Research Reviews - Wiley Online Library Selective targeting of antiapoptotic BCL‐2 proteins in cancer - Timucin - 2019 - Medicinal Research Reviews - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/4332d89b-c0df-4927-9e26-daedbefd05ad/med21516-fig-0003-m.jpg)
Selective targeting of antiapoptotic BCL‐2 proteins in cancer - Timucin - 2019 - Medicinal Research Reviews - Wiley Online Library
![Selective targeting of antiapoptotic BCL‐2 proteins in cancer - Timucin - 2019 - Medicinal Research Reviews - Wiley Online Library Selective targeting of antiapoptotic BCL‐2 proteins in cancer - Timucin - 2019 - Medicinal Research Reviews - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1494bb2f-a60e-491e-951f-7f9680dc0230/med21516-fig-0005-m.jpg)
Selective targeting of antiapoptotic BCL‐2 proteins in cancer - Timucin - 2019 - Medicinal Research Reviews - Wiley Online Library
![Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity - ScienceDirect Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960894X16302529-gr5.jpg)
Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity - ScienceDirect
![Dual Inhibition of Bcl-2 and Bcl-xL Strikingly Enhances PI3K Inhibition-Induced Apoptosis in Human Myeloid Leukemia Cells through a GSK3- and Bim-Dependent Mechanism | Cancer Research Dual Inhibition of Bcl-2 and Bcl-xL Strikingly Enhances PI3K Inhibition-Induced Apoptosis in Human Myeloid Leukemia Cells through a GSK3- and Bim-Dependent Mechanism | Cancer Research](https://cancerres.aacrjournals.org/content/canres/73/4/1340/F7.large.jpg)
Dual Inhibition of Bcl-2 and Bcl-xL Strikingly Enhances PI3K Inhibition-Induced Apoptosis in Human Myeloid Leukemia Cells through a GSK3- and Bim-Dependent Mechanism | Cancer Research
![Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity - ScienceDirect Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960894X16302529-gr13.jpg)
Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity - ScienceDirect
BCL-XL inhibition sensitizes human HSPCs to certain cytotoxic drugs. a,... | Download Scientific Diagram
![Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy | Science Translational Medicine Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy | Science Translational Medicine](https://stm.sciencemag.org/content/scitransmed/7/279/279ra40/F1.large.jpg)
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy | Science Translational Medicine
![NOXA-dependent contextual synthetic lethality of BCL-XL inhibition and “osmotic reprogramming” in colorectal cancer | Cell Death & Disease NOXA-dependent contextual synthetic lethality of BCL-XL inhibition and “osmotic reprogramming” in colorectal cancer | Cell Death & Disease](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41419-020-2446-8/MediaObjects/41419_2020_2446_Fig1_HTML.png)
NOXA-dependent contextual synthetic lethality of BCL-XL inhibition and “osmotic reprogramming” in colorectal cancer | Cell Death & Disease
![Targeting cancer's Achilles' heel: role of BCL-2 inhibitors in cellular senescence and apoptosis | Future Medicinal Chemistry Targeting cancer's Achilles' heel: role of BCL-2 inhibitors in cellular senescence and apoptosis | Future Medicinal Chemistry](https://www.future-science.com/cms/10.4155/fmc-2018-0366/asset/images/medium/figure2.gif)
Targeting cancer's Achilles' heel: role of BCL-2 inhibitors in cellular senescence and apoptosis | Future Medicinal Chemistry
![Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity - ScienceDirect Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960894X16302529-fx1.jpg)